Similar Search Results

Generic drugopoly : why non-patented prescription drugs cost more in Canada than in the United States and Europe

Skinner, Brett J. - 2004

Persistent link: https://www.econbiz.de/10002179264

The efficient use of pharmaceuticals : does Europe have any lessons for a Medicare drug benefit?

Towse, Adrian - In: Health affairs : at the intersection of health, health … 22 (2003) 3, pp. 42-45

Persistent link: https://www.econbiz.de/10001767925

Timely access to new pharmaceuticals in Canada, the United States, and the European Union

Barua, Bacchus; Westcott, Will; Van Nghiem Vo - 2021

Persistent link: https://www.econbiz.de/10012534599

Converging hybrid worlds? : medicine and hospital management in Europe

Dent, Mike (contributor) - 2014

Persistent link: https://www.econbiz.de/10010391792

Patent and access to medicine : constriants for the use of flexibilities

Gopakumar, K. M. - In: Access to medicines in India, (pp. 105-144). 2014

Persistent link: https://www.econbiz.de/10010463463

Access to Medicines and European Market Integration

Pammolli, Fabio - 2016

In this paper we document a process of price convergence in the European market for pharmaceutical products and relate it to access to innovative medicines in individual countries. The EU is a peculiar case study, where free circulation of goods coexists with pricing policies designed and...

Persistent link: https://www.econbiz.de/10013001124